Signal machine
Vente groupé actif — 9 initiés distincts, $7.7M, fenêtre close le Sep 2, 2026.
Chiffres calculés à partir des déclarations réglementaires officielles — .
Analystesobjectif 171.33 USD (+50%) · consensus 4.87/5 · 15 achat · 0 conserver · 0 vente
Détentioninitiés 1.17% · institutions 107.84% · vente à découvert 9.3% du flottant
En USD · au Oct 19, 2026
Interroger la machine
Recherchez et comparez les opérations d’initiés, les sociétés et leurs statistiques en langage courant. Votre question devient une requête sur les données disponibles, pas une conversation ni un conseil en investissement.
Données de iRhythm Holdings, Inc. uniquement. Pas de recherche web. Les statistiques globales d’un initié sont exclues.
Une recherche exécutée consomme un crédit, même sans résultat. Les erreurs et les questions non prises en charge ne consomment rien.
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Source des informations de marché · Oct 19, 2026
Périodes présentes dans les registres consultés. Elles ne certifient pas les dates juridiques de changement de nom.
Identité selon la SEC · Oct 19, 2026
Chronologie sur le marché · historique complet
7 achats439 ventes— cours de clôturebarre = volume usd, échelle √cliquez sur une période pour filtrer le tableau
| Initié | Type | Valeur · USD | Signaux | Détail | |
|---|---|---|---|---|---|
| Wilson Daniel G. | Vente | $94.2K | SEC | ||
| Murphy Patrick Michael | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC | ||
| Turakhia Minang | Vente | $884.2K | SEC | ||
| Patterson Chad | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC | ||
| Turakhia Minang | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC | ||
| Shrishrimal Sumi | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC | ||
| Murphy Patrick Michael | Vente | $884.2K | SEC | ||
| Shrishrimal Sumi | Vente | $669.6K | SEC | ||
| Patterson Chad | Vente | $884.2K | SEC | ||
| Blackford Quentin S.historique | Vente | $3.3M | Taille inhabituelle | SEC | |
| Blackford Quentin S.historique | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC | ||
| Patterson Chad | Vente | $331.2K | SEC | ||
| Smith Mervin | Vente | $75.3K | SEC | ||
| Rodda Julianne | Vente | $257.9K | SEC | ||
| Turakhia Minang | Vente | $177.5K | SEC | ||
| Freeman Sean Clinton | Vente | $114.5K | SEC | ||
| Shrishrimal Sumi | Attribution | $12.9K | Taille inhabituelle | SEC | |
| Shrishrimal Sumi | Vente | $185.7K | SEC | ||
| Rosenbaum Marc Wade | Vente | $78.9K | SEC | ||
| Rosenbaum Marc Wade | Attribution | $17.2K | SEC | ||
| Patterson Chad | Attribution | $17.1K | Taille inhabituelle | SEC | |
| Freeman Sean Clinton | Attribution | $26.4K | SEC | ||
| Turakhia Minang | Attribution | $13.3K | SEC | ||
| Blackford Quentin S.historique | Attribution | $17.2K | SEC | ||
| Ling Karen | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |